Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2018 · 10-Q
Revenue$122.00K$122.00K−9.6% vs Q1 2017 Net Income-$3.83M-$3.83MN/M vs Q1 2017 EPS Diluted-$0.42-$0.42N/M vs Q1 2017 Operating Income-$3,361,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,113,000N/M Margins · derivedOperating margin-2754.9%−418.6 pt vs Q1 2017
Net margin-3136.1%−868.7 pt vs Q1 2017
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end